Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Benitec Biopharma (BNTC) Profit After Tax (2019 - 2025)

Historic Profit After Tax for Benitec Biopharma (BNTC) over the last 7 years, with Q2 2025 value amounting to -$8.8 million.

  • Benitec Biopharma's Profit After Tax fell 8462.99% to -$8.8 million in Q2 2025 from the same period last year, while for Jun 2025 it was -$38.0 million, marking a year-over-year decrease of 7375.26%. This contributed to the annual value of -$37.9 million for FY2025, which is 7393.12% down from last year.
  • As of Q2 2025, Benitec Biopharma's Profit After Tax stood at -$8.8 million, which was down 8462.99% from -$14.5 million recorded in Q1 2025.
  • Benitec Biopharma's Profit After Tax's 5-year high stood at -$3.3 million during Q1 2022, with a 5-year trough of -$14.5 million in Q1 2025.
  • Moreover, its 5-year median value for Profit After Tax was -$5.1 million (2021), whereas its average is -$5.9 million.
  • Its Profit After Tax has fluctuated over the past 5 years, first skyrocketed by 1621.9% in 2022, then tumbled by 23888.76% in 2025.
  • Over the past 5 years, Benitec Biopharma's Profit After Tax (Quarter) stood at -$4.8 million in 2021, then decreased by 12.24% to -$5.4 million in 2022, then dropped by 25.63% to -$6.8 million in 2023, then plummeted by 40.51% to -$9.6 million in 2024, then increased by 7.82% to -$8.8 million in 2025.
  • Its last three reported values are -$8.8 million in Q2 2025, -$14.5 million for Q1 2025, and -$9.6 million during Q4 2024.